Risultati della ricerca - Chamara Basnayake

Response to: Can Disorders of Gut‐Brain Interaction Be Quantified in Systemic Sclerosis Without Excluding Dysmotility? di Kate Seaton, Chamara Basnayake, Laura Ross

Testo

Role of social media in the presentation of disorders of gut–brain interaction: Review and recommendations di Michael R Salzberg, Hannah Kim, Chamara Basnayake, Darcy Holt, Michael A Kamm

Testo

Quantifying the Prevalence of Disorders of Gut Brain Interaction in Systemic Sclerosis di Kate Seaton, Alannah Quinlivan, Nava Ferdowsi, Wendy Stevens, Chamara Basnayake, Laura Ross

Testo

Probiotics: are they beneficial? di Sasha R. Fehily, Chamara Basnayake, Emily K. Wright, C. K. Yao, Jack Godsell, Peter R. Gibson, Michael A. Kamm

Testo

Disorders of gut–brain interaction, eating disorders and gastroparesis: a call for coordinated care and guidelines on nutrition support di Trina Kellar, Chamara Basnayake, Rebecca E Burgell, Michael Kamm, Hannah W Kim, Kate Lane, Kate Murphy, Nicholas J Talley

Testo

Prevalence and Risk Factors for Esophageal Strictures in Systemic Sclerosis di Alannah Quinlivan, Dylan Hansen, Wendy Stevens, Nava Ferdowsi, Susanna Proudman, Jennifer Walker, Joanne Sahhar, Gene‐Siew Ngian, Diane Apostolopoulos, Lauren V. Host, Chamara Basnayake, Kathleen Morrisroe, Laura Ross, Mandana Nikpour

Testo

Research Communication: Real‐World Effectiveness of Budesonide Orodispersible Tablets for Eosinophilic Oesophagitis: The Importance of Patience and Education di Sarah Taylor, Emily Barwick, Varan Perananthan, Nikita Parkash, Sarah Lucas, Ayushi Chauhan, Catherine Yu, Katrina Tan, Gloria Sepe, Mani Suleiman, Diana Lewis, Chamara Basnayake, Hamish Philpott, Sanjay Nandurkar, Rebecca Burgell, Mayur Garg

Testo

Editorial: Intestinal Ultrasound for the Assessment of Constipation—Out of the Shadows? Authors' Reply di Ryan M. Mathias, Thomas M. Goodsall, Claire E. Parker, Alice S. Day, Yoon K. An, Brandon Baraty, Chamara Basnayake, Jakob Begun, Ray K. Boyapati, Rebecca Burgell, Michael T. Dolinger, Giovanni Maconi, Kerri L. Novak, Shintaro Sagami, Rebecca L. Smith, Ashish R. Srinivasan, Stuart A. Taylor, Vipul Jairath, Christopher Ma, Robert V. Bryant

Testo

6‐Thioguanine nucleotide levels are associated with infliximab but not adalimumab levels in inflammatory bowel disease patients on combination therapy di Natalie Yu, Tanya Lee, Daniel Tassone, Sara Vogrin, Steven Phan, Damien M. Wu, Jason Zhang, Luke Wang, Jason Tjahyadi, Krishneel Dutt, Hana Liou, Chamara Basnayake, Emily Wright, Ola Niewiadomski, Mark Lust, Julien Schulberg, Michael A. Kamm, William Connell, Alexander J. Thompson, Ida Hilmi, Raja A. Raja Ali, Shu C. Wei, Peter De Cruz, Antony B. Friedman, Gregory T. Moore, Daniel Van Langenberg, Nik S. Ding

Testo